लोड हो रहा है
Slzii.com खोज
खोज (समाचार)
Roivant To Present Topline Results From The Phase 2 Phocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) At The ERS Congress 2026 On Tuesday, September 8, 2026, And Host Investor Call
english top health
(MENAFN - GlobeNewsWire - Nasdaq) BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Pulmovant today announced that results from the Phase 2 ...
2026-09-06 01:01:09
लिंक
खेल
वेब खोज
एनालिटिक्स
मुफ़्त ईमेल/वेबमेल
वेबशॉप
मुफ़्त उप-डोमेन
छोटा यूआरएल
चैटजीपीटी
औजार
वेबनिर्देशिका
विकि
परिवहन
कार्यसूची
संपर्क